SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-140107
Filing Date
2016-12-19
Accepted
2016-12-19 06:06:23
Documents
3
Period of Report
2016-12-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v455224_8k.htm 8-K 14679
2 EXHIBIT 99.1 v455224_ex99-1.htm EX-99.1 11250
3 EXHIBIT 99.2 v455224_ex99-2.htm EX-99.2 18355
  Complete submission text file 0001144204-16-140107.txt   45785
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 162057741
SIC: 2836 Biological Products, (No Diagnostic Substances)